We are live on ! Find out more
Envestnet Asset Management

Envestnet Asset Management Portfolio holdings

AUM $424B
1-Year Est. Return 22.96%
 

Envestnet Asset Management, a subsidiary of Envestnet, Inc., founded in 1999 by Jud Bergman and Bill Crager, is a Chicago-based financial technology firm that provides wealth management solutions and software to financial advisors and institutions, managing over $426 billion in discretionary assets as of late 2024. Headquartered at 35 East Wacker Drive, it serves a vast network, including over 111,000 advisors and major U.S. banks, with a platform overseeing more than $6.5 trillion in assets, offering tools like portfolio management, trading, and reporting through an integrated ecosystem. Known for its innovative AdvisorSuite software and Portfolio Management Consultants (PMC) division, Envestnet supports advisors with sub-advisory services, research, and data analytics, bolstered by its 2015 acquisition of Yodlee for enhanced data aggregation. Recently acquired by a Bain Capital-led consortium for $4.5 billion in November 2024, Envestnet continues to evolve as a private entity, focusing on scalable, tech-driven wealth management solutions.

This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+22.96%
3 Year Est. Return
+65.02%
5 Year Est. Return
+65.25%
10 Year Est. Return
+249.9%
AUM
$36.2B
AUM Growth
+$4.93B
Cap. Flow
+$4.18B
Cap. Flow %
11.56%
Top 10 Hldgs %
31%
Holding
3,249
New
83
Increased
1,247
Reduced
1,488
Closed
133

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Healthcare 2.74%
3 Financials 2.67%
4 Industrials 2.04%
5 Consumer Discretionary 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HR
1926
DELISTED
Healthcare Realty Trust Incorporated
HR
$171K ﹤0.01%
5,041
+654
+15% +$22K
HSKA
1927
DELISTED
Heska Corp
HSKA
$170K ﹤0.01%
1,662
+72
+5% +$7.11K
FTC icon
1928
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.36B
$169K ﹤0.01%
3,056
-362
-11% -$19.5K
DPLO
1929
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$169K ﹤0.01%
11,461
-24
-0.2% -$400
HHH icon
1930
Howard Hughes
HHH
$4.06B
$168K ﹤0.01%
1,435
-44
-3% -$5.21K
PAYC icon
1931
Paycom
PAYC
$10.1B
$168K ﹤0.01%
2,449
-231
-9% -$14.9K
HEP
1932
DELISTED
Holly Energy Partners, L.P.
HEP
$168K ﹤0.01%
5,161
-260
-5% -$8.85K
FND icon
1933
Floor & Decor
FND
$6.39B
$167K ﹤0.01%
+4,243
New +$165K
KFY icon
1934
Korn Ferry
KFY
$4.2B
$167K ﹤0.01%
4,797
-3,359
-41% -$109K
MGPI icon
1935
MGP Ingredients
MGPI
$371M
$167K ﹤0.01%
3,264
+64
+2% +$3.34K
HMHC
1936
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$167K ﹤0.01%
13,608
+11,165
+457% +$137K
MGLN
1937
DELISTED
Magellan Health Services, Inc.
MGLN
$167K ﹤0.01%
2,292
-1,441
-39% -$101K
TIF
1938
DELISTED
Tiffany & Co.
TIF
$166K ﹤0.01%
1,783
-4,239
-70% -$389K
PBE icon
1939
Invesco Biotechnology & Genome ETF
PBE
$287M
$165K ﹤0.01%
3,608
+1,091
+43% +$47.1K
PPLT
1940
abrdn Physical Platinum Shares ETF
PPLT
$1.99B
$165K ﹤0.01%
18,680
+20
+0.1% +$180
BANF icon
1941
BancFirst
BANF
$3.81B
$162K ﹤0.01%
3,356
+356
+12% +$16.9K
DBB icon
1942
Invesco DB Base Metals Fund
DBB
$317M
$162K ﹤0.01%
9,884
-140,199
-93% -$2.22M
PLUS icon
1943
ePlus
PLUS
$2.36B
$162K ﹤0.01%
4,392
+4,188
+2,053% +$152K
DBE icon
1944
Invesco DB Energy Fund
DBE
$85.7M
$161K ﹤0.01%
+13,898
New +$167K
ETV
1945
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.75B
$161K ﹤0.01%
10,613
-13,044
-55% -$201K
NTUS
1946
DELISTED
Natus Medical Inc
NTUS
$161K ﹤0.01%
4,291
-8,510
-66% -$307K
FDC
1947
DELISTED
First Data Corporation
FDC
$161K ﹤0.01%
8,834
-1,319
-13% -$22.1K
SLGN icon
1948
Silgan Holdings
SLGN
$4.39B
$160K ﹤0.01%
4,988
+344
+7% +$10.6K
LPT
1949
DELISTED
Liberty Property Trust
LPT
$160K ﹤0.01%
3,957
-1,779
-31% -$73.1K
BMVP icon
1950
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
$159K ﹤0.01%
5,598
+3
+0.1% +$85

Similar funds

Envestnet Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Envestnet Asset Management held 3,249 positions worth $36.2B, up 16% from $31.2B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Envestnet Asset Management deployed $4.18B of net new capital in Q2 2017, opening 83 new positions and adding to 1,247 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 644,052 shares worth $17.9M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Core S&P Total US Stock Market ETF, an estimated $73M trimmed.

  • Envestnet Asset Management's largest Q2 2017 buy was iShares US Medical Devices ETF: 644,052 shares worth $17.9M.
  • Envestnet Asset Management added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $532M increase.
  • Envestnet Asset Management's biggest Q2 2017 reduction was iShares Core S&P Total US Stock Market ETF, cutting an estimated $73M.
  • Envestnet Asset Management fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q2 2017, selling an estimated $18.2M.
  • Envestnet Asset Management's ten largest holdings make up 31% of its $36.2B portfolio in Q2 2017.
  • Envestnet Asset Management opened 83 new positions and closed 133 in Q2 2017.
  • Envestnet Asset Management's portfolio value rose 16% quarter-over-quarter to $36.2B.

Based on Envestnet Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.